Trials / Not Yet Recruiting
Not Yet RecruitingNCT06722820
Study to Evaluate LPH-5 in Healthy Subjects
Phase I, First-in-man, Randomised, Placebo-controlled, Single Dose Escalation Study to Investigate the Effects of LPH-5 on Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Parameters in Healthy Participants
- Status
- Not Yet Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 48 (estimated)
- Sponsor
- Lophora · Industry
- Sex
- Male
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This study will explore the safety, pharmacokinetics (PK) and pharmacodynamics (PD) of LPH-5.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LPH-5 | LPH-5 |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2025-04-30
- Primary completion
- 2025-11-30
- Completion
- 2025-12-31
- First posted
- 2024-12-09
- Last updated
- 2024-12-09
Source: ClinicalTrials.gov record NCT06722820. Inclusion in this directory is not an endorsement.